Kathleen Lynch (Cork North Central, Labour) | Oireachtas source

We cannot pre-empt the outcome of the discussions but the fact that they are ongoing is positive. We already have the results of the investigations on the effectiveness of the drug and the engagement with clinicians. The information is being considered as well. In the past we have agreed to reimburse extraordinarily expensive drugs. It is not always about the price; it is about their effectiveness as well. We are engaging on the matter in the manner outlined. I would not say that all hope is lost. I believe that we will find a solution. As with other drugs, I appeal to manufacturers to be sensible and reasonable about the type of hope drugs can offer people who clearly would be very distressed at getting certain diagnoses. We need to continue to engage with both the manufacturers and the clinicians on the matter. We have not yet concluded the process but I would be hopeful that it will conclude at a very early stage.